WinstonWınston
Back
Sigma Healthcare Limited logo

Sigma Healthcare Limited

SIG.AX
38
Medical - Distribution · Healthcare
Price
A$2.90
+0.00 (+0.00%)
Market Cap
A$33.48B
Exchange
Australian Securities Exchange
Winston Score
38
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Strong
Valuation
Data not available
Dividends
Good

Share count rising — dilution

+51.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.03B (2021) → 1.57B (2025)

Winston Score History

The full picture

Sigma Healthcare is an Australian company that supplies medicines and health products to pharmacies across Australia. It distributes prescription drugs, over-the-counter medicines, and general health goods to thousands of independent and branded pharmacy stores. Sigma is one of Australia's largest pharmaceutical wholesalers and also supports the Amcal and Guardian pharmacy banner networks.

The company earns money by buying medicines in bulk from manufacturers and selling them to pharmacies at a markup, keeping a small margin on each transaction. It operates almost entirely within Australia and recently completed a major merger with Chemist Warehouse, one of Australia's largest retail pharmacy chains, significantly expanding its scale. The key growth opportunity is capturing more volume through the Chemist Warehouse relationship, but the main risk is that thin distribution margins leave little room for error if costs rise or pricing pressure increases from suppliers or competitors.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+235.8% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+607.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

A$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

56.1%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

A$1.1B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Sigma Healthcare Limited grew revenue 236% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
18.3%
Thin — 18.3% gross margin
Profit after running costs
Operating Margin
9.9%
Modest — 9.9% operating margin
Return on the money invested
ROCE
7.5%
Weak — 7.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+144.5%
Fast-growing sales (+144.5% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
30%
Weak — only 30% of profit becomes cash
Spare cash per sale
FCF Margin
0.9%
Thin free cash flow (0.9%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.41
Conservative — low debt load (0.41)
Covers its interest
Interest Cover
12.88x
Comfortably covers interest (12.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.11%
Small dividend — 1.11% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+72.0%
Dividend growing fast (72.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial